Quick Comparison
| PEA (Palmitoylethanolamide) | Taurine | |
|---|---|---|
| Half-Life | 1-2 hours (rapidly metabolized). Micronized forms have improved bioavailability | 1-2 hours (plasma), but brain levels persist longer |
| Typical Dosage | Standard: 300-1200 mg daily in 2-3 divided doses. Start at 600 mg daily. Micronized or ultra-micronized (um-PEA) forms have much better absorption. For chronic pain: 600 mg twice daily. For neuroinflammation: 400-600 mg twice daily. Effects build over 2-4 weeks. | Standard: 500-2000 mg daily. Anti-aging research (animal-equivalent): 1000-3000 mg daily. Can be taken at any time of day. |
| Administration | Oral (capsules, powder). Micronized (m-PEA) or ultra-micronized (um-PEA) forms preferred for bioavailability. | Oral (capsules, powder, present in energy drinks at subtherapeutic doses). |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
PEA (Palmitoylethanolamide)
PEA activates PPAR-alpha (peroxisome proliferator-activated receptor alpha), a nuclear receptor that heterodimerizes with RXR and downregulates pro-inflammatory gene expression (NF-kB target genes, COX-2, iNOS, TNF-alpha). It has an 'entourage effect' on the endocannabinoid system — it inhibits the degradation of anandamide by fatty acid amide hydrolase (FAAH) through allosteric modulation or substrate competition, and upregulates CB2 receptor expression on immune cells. This provides anti-inflammatory and analgesic effects without directly activating CB1/CB2. PEA also activates GPR55 and GPR119. It inhibits mast cell degranulation (reducing histamine, tryptase, and cytokine release) and reduces microglial activation in the brain (inhibiting Iba1 expression and pro-inflammatory cytokine production). PEA may also modulate TRPV1.
Taurine
Taurine activates GABA-A receptors (particularly extrasynaptic δ-containing subtypes) and glycine receptors (GlyR) as a partial agonist, providing inhibitory modulation that reduces neural excitability and hyperexcitability. It acts as a powerful antioxidant, scavenging hypochlorous acid, hydroxyl radicals, and peroxynitrite in mitochondria and cytosol. Taurine regulates calcium homeostasis via modulation of ryanodine receptors and IP3 receptors, preventing excitotoxic calcium overload. It modulates osmotic balance through the taurine transporter (TauT/SLC6A6) to protect cells from swelling under stress. Taurine may enhance mitochondrial function and biogenesis. Recent research shows it maintains telomere length, reduces cellular senescence markers (p16, p21), and modulates the mTOR pathway.
Risks & Safety
PEA (Palmitoylethanolamide)
Common
Very well-tolerated — rare side effects. Mild GI discomfort.
Serious
None documented. Over 30 clinical trials confirm excellent safety profile.
Rare
Skin rash.
Taurine
Common
Very few — taurine has an excellent safety profile. Mild digestive discomfort at very high doses.
Serious
None documented at standard supplemental doses. Safe up to 6000 mg daily in studies.
Rare
Drowsiness, lowered blood pressure.
Full Profiles
PEA (Palmitoylethanolamide) →
An endogenous fatty acid amide produced naturally in the body in response to pain and inflammation. PEA activates PPAR-alpha receptors and indirectly enhances endocannabinoid signaling without binding to cannabinoid receptors. It has strong evidence for neuropathic pain, neuroinflammation, and neuroprotection. Unlike anti-inflammatory drugs, it resolves inflammation rather than merely suppressing it.
Taurine →
An abundant amino acid in the brain that acts as a major inhibitory neuromodulator, antioxidant, and osmolyte (cell volume regulator). Despite its association with energy drinks, taurine is actually calming — it modulates GABA receptors and reduces neural excitability. Recent research has shown taurine supplementation reverses aging markers in multiple organ systems including the brain.